| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diabetes Mellitus, Type 2 | 16 | 2024 | 674 | 4.080 |
Why?
|
| Telemedicine | 9 | 2025 | 335 | 2.670 |
Why?
|
| Diabetes Mellitus | 10 | 2017 | 537 | 2.110 |
Why?
|
| Self Care | 12 | 2025 | 211 | 1.680 |
Why?
|
| Text Messaging | 4 | 2025 | 74 | 1.650 |
Why?
|
| Pharmacists | 5 | 2020 | 123 | 1.470 |
Why?
|
| Patient Education as Topic | 7 | 2024 | 446 | 1.360 |
Why?
|
| Feasibility Studies | 7 | 2025 | 524 | 1.330 |
Why?
|
| Urban Population | 6 | 2017 | 182 | 1.280 |
Why?
|
| Medication Adherence | 5 | 2020 | 255 | 1.260 |
Why?
|
| Health Education | 4 | 2017 | 184 | 1.130 |
Why?
|
| Community Health Workers | 3 | 2017 | 37 | 1.100 |
Why?
|
| Diabetes, Gestational | 2 | 2021 | 144 | 1.100 |
Why?
|
| Hypoglycemic Agents | 4 | 2020 | 212 | 1.090 |
Why?
|
| Obesity | 10 | 2024 | 1186 | 0.990 |
Why?
|
| Middle Aged | 39 | 2025 | 16277 | 0.990 |
Why?
|
| Weight Loss | 6 | 2021 | 260 | 0.910 |
Why?
|
| Female | 54 | 2025 | 30920 | 0.910 |
Why?
|
| Prediabetic State | 3 | 2023 | 52 | 0.900 |
Why?
|
| Humans | 78 | 2025 | 59520 | 0.890 |
Why?
|
| Aggression | 1 | 2024 | 57 | 0.880 |
Why?
|
| Self-Management | 1 | 2024 | 62 | 0.870 |
Why?
|
| Resilience, Psychological | 1 | 2024 | 50 | 0.860 |
Why?
|
| Adult | 32 | 2025 | 15789 | 0.850 |
Why?
|
| Internet | 5 | 2013 | 458 | 0.820 |
Why?
|
| Physicians | 3 | 2017 | 436 | 0.800 |
Why?
|
| Health Promotion | 6 | 2018 | 491 | 0.780 |
Why?
|
| Surveys and Questionnaires | 9 | 2018 | 2592 | 0.770 |
Why?
|
| Hypoglycemia | 1 | 2022 | 68 | 0.750 |
Why?
|
| Chicago | 9 | 2024 | 25 | 0.720 |
Why?
|
| Metformin | 1 | 2021 | 67 | 0.700 |
Why?
|
| Self Efficacy | 3 | 2024 | 201 | 0.700 |
Why?
|
| Pilot Projects | 8 | 2024 | 919 | 0.670 |
Why?
|
| Educational Status | 3 | 2023 | 271 | 0.660 |
Why?
|
| Male | 41 | 2025 | 27574 | 0.640 |
Why?
|
| Survivors | 2 | 2017 | 148 | 0.610 |
Why?
|
| Exercise | 7 | 2025 | 916 | 0.600 |
Why?
|
| Programming Languages | 1 | 2017 | 15 | 0.580 |
Why?
|
| Defibrillators | 1 | 2017 | 16 | 0.580 |
Why?
|
| Soccer | 1 | 2017 | 13 | 0.570 |
Why?
|
| Aged | 27 | 2025 | 13342 | 0.570 |
Why?
|
| Internship and Residency | 2 | 2024 | 727 | 0.570 |
Why?
|
| Transportation Facilities | 1 | 2017 | 1 | 0.560 |
Why?
|
| Architectural Accessibility | 1 | 2017 | 5 | 0.560 |
Why?
|
| Weight Reduction Programs | 2 | 2017 | 57 | 0.560 |
Why?
|
| Health Literacy | 3 | 2012 | 77 | 0.560 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2022 | 607 | 0.550 |
Why?
|
| Quality of Life | 9 | 2023 | 1117 | 0.550 |
Why?
|
| Depression | 5 | 2023 | 857 | 0.550 |
Why?
|
| Research Personnel | 1 | 2017 | 86 | 0.540 |
Why?
|
| Out-of-Hospital Cardiac Arrest | 1 | 2017 | 45 | 0.540 |
Why?
|
| Geography, Medical | 1 | 2016 | 5 | 0.530 |
Why?
|
| Physician-Patient Relations | 4 | 2018 | 388 | 0.530 |
Why?
|
| Renal Insufficiency, Chronic | 4 | 2020 | 114 | 0.530 |
Why?
|
| Transportation of Patients | 1 | 2017 | 42 | 0.530 |
Why?
|
| Angiotensin Receptor Antagonists | 2 | 2016 | 63 | 0.530 |
Why?
|
| Pharmacies | 1 | 2016 | 36 | 0.520 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 2017 | 85 | 0.520 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 2 | 2016 | 142 | 0.520 |
Why?
|
| Multimedia | 3 | 2011 | 10 | 0.520 |
Why?
|
| Blood Glucose | 4 | 2023 | 471 | 0.510 |
Why?
|
| Breast Neoplasms | 4 | 2025 | 1129 | 0.490 |
Why?
|
| Warfarin | 2 | 2012 | 109 | 0.460 |
Why?
|
| Health Behavior | 3 | 2024 | 473 | 0.460 |
Why?
|
| Health Knowledge, Attitudes, Practice | 5 | 2017 | 741 | 0.460 |
Why?
|
| Videotape Recording | 2 | 2013 | 46 | 0.450 |
Why?
|
| Communication Barriers | 3 | 2018 | 59 | 0.450 |
Why?
|
| Patient Satisfaction | 2 | 2024 | 410 | 0.440 |
Why?
|
| Mass Screening | 2 | 2016 | 647 | 0.440 |
Why?
|
| Disabled Persons | 2 | 2013 | 205 | 0.440 |
Why?
|
| Practice Patterns, Physicians' | 3 | 2020 | 715 | 0.420 |
Why?
|
| Mobility Limitation | 2 | 2010 | 49 | 0.400 |
Why?
|
| Herb-Drug Interactions | 1 | 2012 | 4 | 0.400 |
Why?
|
| Lycium | 1 | 2012 | 3 | 0.400 |
Why?
|
| Drugs, Chinese Herbal | 1 | 2012 | 9 | 0.400 |
Why?
|
| Cancer Survivors | 2 | 2025 | 80 | 0.390 |
Why?
|
| Mobile Applications | 3 | 2025 | 130 | 0.380 |
Why?
|
| Beverages | 1 | 2012 | 65 | 0.380 |
Why?
|
| Overweight | 1 | 2013 | 247 | 0.380 |
Why?
|
| Patient-Centered Care | 4 | 2025 | 249 | 0.370 |
Why?
|
| Glycemic Index | 1 | 2011 | 25 | 0.370 |
Why?
|
| Heart Failure | 3 | 2025 | 867 | 0.350 |
Why?
|
| United States | 16 | 2022 | 7514 | 0.350 |
Why?
|
| Sleep | 3 | 2023 | 219 | 0.340 |
Why?
|
| Insurance, Health | 1 | 2011 | 141 | 0.330 |
Why?
|
| Diabetic Retinopathy | 2 | 2020 | 45 | 0.330 |
Why?
|
| Women's Health | 2 | 2010 | 390 | 0.330 |
Why?
|
| Patient Compliance | 3 | 2015 | 372 | 0.330 |
Why?
|
| Medicaid | 1 | 2013 | 335 | 0.320 |
Why?
|
| Poverty | 3 | 2017 | 286 | 0.320 |
Why?
|
| Cell Phone | 1 | 2009 | 43 | 0.310 |
Why?
|
| Primary Health Care | 7 | 2024 | 647 | 0.300 |
Why?
|
| Social Support | 4 | 2013 | 358 | 0.290 |
Why?
|
| Young Adult | 5 | 2024 | 4332 | 0.280 |
Why?
|
| Chronic Disease | 3 | 2025 | 735 | 0.280 |
Why?
|
| Algorithms | 4 | 2006 | 990 | 0.260 |
Why?
|
| Hospitalization | 3 | 2024 | 1283 | 0.260 |
Why?
|
| Urinary Tract Infections | 1 | 2006 | 76 | 0.240 |
Why?
|
| Cross-Over Studies | 2 | 2017 | 149 | 0.240 |
Why?
|
| Technology | 2 | 2021 | 50 | 0.240 |
Why?
|
| Computer-Assisted Instruction | 1 | 2005 | 81 | 0.240 |
Why?
|
| Adolescent | 6 | 2024 | 5932 | 0.240 |
Why?
|
| Public Health Informatics | 1 | 2004 | 7 | 0.230 |
Why?
|
| Blood Pressure | 4 | 2021 | 522 | 0.230 |
Why?
|
| Access to Information | 1 | 2004 | 30 | 0.230 |
Why?
|
| Severity of Illness Index | 1 | 2009 | 1449 | 0.230 |
Why?
|
| Research | 2 | 2006 | 191 | 0.230 |
Why?
|
| Qualitative Research | 3 | 2024 | 612 | 0.220 |
Why?
|
| Melatonin | 2 | 2020 | 66 | 0.220 |
Why?
|
| Wearable Electronic Devices | 1 | 2024 | 63 | 0.220 |
Why?
|
| Logistic Models | 5 | 2016 | 1252 | 0.210 |
Why?
|
| Multivariate Analysis | 3 | 2016 | 926 | 0.200 |
Why?
|
| Telephone | 4 | 2022 | 121 | 0.200 |
Why?
|
| Blood Glucose Self-Monitoring | 1 | 2022 | 58 | 0.200 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2022 | 137 | 0.190 |
Why?
|
| Sexually Transmitted Diseases | 1 | 2022 | 93 | 0.190 |
Why?
|
| Pregnancy | 2 | 2021 | 2355 | 0.190 |
Why?
|
| Drug Utilization | 2 | 2020 | 223 | 0.190 |
Why?
|
| Models, Neurological | 2 | 1993 | 81 | 0.190 |
Why?
|
| Electronic Health Records | 1 | 2024 | 352 | 0.190 |
Why?
|
| Vascular Stiffness | 1 | 2021 | 14 | 0.190 |
Why?
|
| Psychometrics | 3 | 2017 | 356 | 0.180 |
Why?
|
| Pennsylvania | 1 | 2021 | 56 | 0.180 |
Why?
|
| Self-Control | 1 | 2020 | 6 | 0.180 |
Why?
|
| Cooperative Behavior | 3 | 2015 | 220 | 0.180 |
Why?
|
| Actigraphy | 1 | 2021 | 47 | 0.170 |
Why?
|
| Health Services Accessibility | 2 | 2017 | 542 | 0.170 |
Why?
|
| Adie Syndrome | 1 | 2020 | 1 | 0.170 |
Why?
|
| Sleep Disorders, Circadian Rhythm | 1 | 2020 | 5 | 0.170 |
Why?
|
| Retinal Ganglion Cells | 1 | 2020 | 27 | 0.170 |
Why?
|
| Dipeptidyl-Peptidase IV Inhibitors | 1 | 2020 | 11 | 0.170 |
Why?
|
| Drugs, Generic | 1 | 2020 | 17 | 0.170 |
Why?
|
| Pharmacy | 1 | 2020 | 18 | 0.170 |
Why?
|
| Physicians, Women | 1 | 2020 | 42 | 0.170 |
Why?
|
| Atherosclerosis | 1 | 2021 | 147 | 0.160 |
Why?
|
| Nutrition Surveys | 2 | 2019 | 152 | 0.160 |
Why?
|
| Minority Groups | 1 | 2021 | 140 | 0.160 |
Why?
|
| Circadian Clocks | 1 | 2020 | 44 | 0.160 |
Why?
|
| Statistics as Topic | 2 | 2017 | 147 | 0.160 |
Why?
|
| Treatment Outcome | 4 | 2020 | 5183 | 0.160 |
Why?
|
| Time Factors | 5 | 2020 | 3579 | 0.150 |
Why?
|
| Software | 2 | 2009 | 367 | 0.150 |
Why?
|
| Cross-Sectional Studies | 5 | 2020 | 2470 | 0.150 |
Why?
|
| Aged, 80 and over | 4 | 2017 | 5089 | 0.150 |
Why?
|
| Culture | 2 | 2012 | 76 | 0.150 |
Why?
|
| Age Factors | 3 | 2012 | 1518 | 0.140 |
Why?
|
| Pharmaceutical Services | 1 | 2017 | 31 | 0.140 |
Why?
|
| Periodicals as Topic | 1 | 2020 | 173 | 0.140 |
Why?
|
| Retrospective Studies | 3 | 2020 | 6011 | 0.140 |
Why?
|
| Patient Care Planning | 1 | 2017 | 83 | 0.140 |
Why?
|
| Attitude of Health Personnel | 2 | 2015 | 559 | 0.140 |
Why?
|
| Perception | 2 | 2015 | 179 | 0.140 |
Why?
|
| Pneumonia | 3 | 2005 | 270 | 0.140 |
Why?
|
| Meta-Analysis as Topic | 1 | 2017 | 77 | 0.140 |
Why?
|
| Data Collection | 3 | 2022 | 384 | 0.130 |
Why?
|
| Smartphone | 1 | 2017 | 61 | 0.130 |
Why?
|
| Risk Factors | 5 | 2020 | 5017 | 0.130 |
Why?
|
| Antihypertensive Agents | 1 | 2017 | 172 | 0.130 |
Why?
|
| Veterans Health | 1 | 2017 | 156 | 0.130 |
Why?
|
| Community-Acquired Infections | 4 | 2005 | 87 | 0.130 |
Why?
|
| Socioeconomic Factors | 3 | 2013 | 781 | 0.130 |
Why?
|
| HIV Infections | 1 | 2022 | 921 | 0.130 |
Why?
|
| ROC Curve | 3 | 2012 | 259 | 0.120 |
Why?
|
| Medical Errors | 1 | 2017 | 193 | 0.120 |
Why?
|
| Random Allocation | 1 | 2015 | 199 | 0.120 |
Why?
|
| Behavior Therapy | 2 | 2020 | 161 | 0.120 |
Why?
|
| Models, Statistical | 1 | 2017 | 306 | 0.120 |
Why?
|
| Academic Medical Centers | 1 | 2017 | 314 | 0.120 |
Why?
|
| Analysis of Variance | 2 | 2012 | 576 | 0.120 |
Why?
|
| Follow-Up Studies | 2 | 2012 | 2329 | 0.120 |
Why?
|
| Odds Ratio | 1 | 2016 | 773 | 0.120 |
Why?
|
| Prospective Studies | 3 | 2022 | 3101 | 0.110 |
Why?
|
| Quality of Health Care | 1 | 2018 | 519 | 0.110 |
Why?
|
| Transportation | 1 | 2013 | 33 | 0.110 |
Why?
|
| Professional-Patient Relations | 2 | 2015 | 127 | 0.110 |
Why?
|
| Child, Preschool | 2 | 2017 | 1839 | 0.110 |
Why?
|
| Illinois | 1 | 2013 | 14 | 0.110 |
Why?
|
| Synapses | 2 | 1993 | 177 | 0.100 |
Why?
|
| Child | 3 | 2021 | 4306 | 0.100 |
Why?
|
| Databases, Factual | 1 | 2016 | 838 | 0.100 |
Why?
|
| Drug Utilization Review | 1 | 2013 | 56 | 0.100 |
Why?
|
| Patient Care Team | 1 | 2015 | 327 | 0.100 |
Why?
|
| Potassium | 1 | 1993 | 109 | 0.100 |
Why?
|
| Body Mass Index | 1 | 2016 | 886 | 0.100 |
Why?
|
| International Normalized Ratio | 1 | 2012 | 34 | 0.100 |
Why?
|
| Monitoring, Physiologic | 1 | 1993 | 150 | 0.100 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 1993 | 168 | 0.090 |
Why?
|
| Drug Monitoring | 1 | 2011 | 99 | 0.090 |
Why?
|
| Acculturation | 1 | 2011 | 47 | 0.090 |
Why?
|
| Cost-Benefit Analysis | 1 | 2012 | 299 | 0.090 |
Why?
|
| Ventricular Function, Left | 1 | 1993 | 263 | 0.090 |
Why?
|
| Health Status Indicators | 2 | 2012 | 98 | 0.090 |
Why?
|
| Narration | 1 | 2011 | 44 | 0.090 |
Why?
|
| Motor Activity | 1 | 2013 | 343 | 0.090 |
Why?
|
| User-Computer Interface | 2 | 2009 | 129 | 0.090 |
Why?
|
| Patient Care | 1 | 2011 | 78 | 0.090 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2021 | 673 | 0.090 |
Why?
|
| Peripheral Arterial Disease | 1 | 2012 | 155 | 0.090 |
Why?
|
| Affect | 2 | 2021 | 121 | 0.090 |
Why?
|
| Walking | 1 | 2012 | 229 | 0.090 |
Why?
|
| Smoking Prevention | 1 | 2011 | 162 | 0.090 |
Why?
|
| Nerve Net | 1 | 1991 | 94 | 0.090 |
Why?
|
| Health Status Disparities | 1 | 2011 | 147 | 0.080 |
Why?
|
| Anxiety | 2 | 2023 | 395 | 0.080 |
Why?
|
| Diet, Carbohydrate-Restricted | 1 | 2009 | 10 | 0.080 |
Why?
|
| Research Design | 1 | 2012 | 566 | 0.080 |
Why?
|
| Diet, Fat-Restricted | 1 | 2009 | 36 | 0.080 |
Why?
|
| Diet | 1 | 2013 | 635 | 0.080 |
Why?
|
| Vitamin D | 1 | 2010 | 149 | 0.080 |
Why?
|
| Disease Progression | 3 | 2020 | 1044 | 0.080 |
Why?
|
| Reminder Systems | 1 | 2009 | 72 | 0.080 |
Why?
|
| Forecasting | 2 | 2006 | 221 | 0.070 |
Why?
|
| Anticoagulants | 1 | 2011 | 487 | 0.070 |
Why?
|
| Self-Help Groups | 1 | 2007 | 37 | 0.070 |
Why?
|
| Nebraska | 1 | 2006 | 8 | 0.070 |
Why?
|
| Referral and Consultation | 1 | 2009 | 409 | 0.070 |
Why?
|
| Game Theory | 1 | 2006 | 5 | 0.070 |
Why?
|
| Altruism | 1 | 2006 | 13 | 0.070 |
Why?
|
| Linear Models | 2 | 2010 | 422 | 0.060 |
Why?
|
| Smoking Cessation | 1 | 2011 | 531 | 0.060 |
Why?
|
| Computer Literacy | 1 | 2005 | 3 | 0.060 |
Why?
|
| Medicare | 1 | 2010 | 601 | 0.060 |
Why?
|
| Crossing Over, Genetic | 1 | 2005 | 3 | 0.060 |
Why?
|
| Fitness Trackers | 1 | 2025 | 19 | 0.060 |
Why?
|
| Focus Groups | 2 | 2017 | 292 | 0.060 |
Why?
|
| Computers | 1 | 2005 | 48 | 0.060 |
Why?
|
| Interprofessional Relations | 1 | 2006 | 131 | 0.060 |
Why?
|
| Motivation | 1 | 2006 | 266 | 0.060 |
Why?
|
| Censuses | 1 | 2023 | 14 | 0.060 |
Why?
|
| Rest | 1 | 2023 | 43 | 0.050 |
Why?
|
| Education, Medical, Graduate | 1 | 2006 | 310 | 0.050 |
Why?
|
| Cluster Analysis | 1 | 2023 | 250 | 0.050 |
Why?
|
| Safe Sex | 1 | 2022 | 25 | 0.050 |
Why?
|
| Health Services Needs and Demand | 1 | 2004 | 214 | 0.050 |
Why?
|
| Delivery of Health Care | 1 | 2006 | 421 | 0.050 |
Why?
|
| Georgia | 1 | 2022 | 88 | 0.050 |
Why?
|
| Mathematical Computing | 1 | 2002 | 12 | 0.050 |
Why?
|
| Sampling Studies | 1 | 2002 | 66 | 0.050 |
Why?
|
| Pneumonia, Bacterial | 1 | 2003 | 86 | 0.050 |
Why?
|
| Translating | 1 | 2002 | 17 | 0.050 |
Why?
|
| Biomedical Technology | 1 | 2021 | 6 | 0.050 |
Why?
|
| Decision Making, Computer-Assisted | 1 | 2001 | 12 | 0.050 |
Why?
|
| Pulsatile Flow | 1 | 2021 | 8 | 0.050 |
Why?
|
| Anxiety Disorders | 1 | 2023 | 188 | 0.050 |
Why?
|
| Machine Learning | 1 | 2022 | 136 | 0.050 |
Why?
|
| Incidence | 1 | 2024 | 1238 | 0.050 |
Why?
|
| Carotid Arteries | 1 | 2021 | 59 | 0.050 |
Why?
|
| Medical Informatics | 1 | 2001 | 68 | 0.040 |
Why?
|
| Artificial Intelligence | 1 | 2003 | 166 | 0.040 |
Why?
|
| Reflex, Pupillary | 1 | 2020 | 2 | 0.040 |
Why?
|
| Administrative Claims, Healthcare | 1 | 2020 | 13 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2004 | 675 | 0.040 |
Why?
|
| Insurance, Pharmaceutical Services | 1 | 2020 | 24 | 0.040 |
Why?
|
| Medication Therapy Management | 1 | 2020 | 25 | 0.040 |
Why?
|
| Drug Substitution | 1 | 2020 | 42 | 0.040 |
Why?
|
| Circadian Rhythm | 1 | 2023 | 370 | 0.040 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 1 | 2020 | 47 | 0.040 |
Why?
|
| Diabetic Nephropathies | 1 | 2019 | 38 | 0.040 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2021 | 301 | 0.040 |
Why?
|
| History, 21st Century | 1 | 2019 | 161 | 0.040 |
Why?
|
| Antidepressive Agents | 1 | 2020 | 229 | 0.040 |
Why?
|
| Communication | 2 | 2015 | 554 | 0.040 |
Why?
|
| Cultural Competency | 1 | 2018 | 50 | 0.040 |
Why?
|
| Hydrocortisone | 1 | 2020 | 188 | 0.040 |
Why?
|
| Glomerular Filtration Rate | 1 | 2018 | 96 | 0.040 |
Why?
|
| Comorbidity | 1 | 2021 | 1091 | 0.040 |
Why?
|
| Health Status | 1 | 2021 | 449 | 0.040 |
Why?
|
| Trust | 1 | 2018 | 68 | 0.040 |
Why?
|
| Leadership | 1 | 2020 | 201 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2020 | 1063 | 0.040 |
Why?
|
| Language | 1 | 2018 | 141 | 0.040 |
Why?
|
| Computer Simulation | 2 | 2006 | 455 | 0.030 |
Why?
|
| Kidney Failure, Chronic | 1 | 2018 | 193 | 0.030 |
Why?
|
| Neoplasm Staging | 1 | 2017 | 454 | 0.030 |
Why?
|
| Community Pharmacy Services | 1 | 2015 | 14 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2020 | 2104 | 0.030 |
Why?
|
| Professional Role | 1 | 2015 | 37 | 0.030 |
Why?
|
| Interviews as Topic | 1 | 2017 | 486 | 0.030 |
Why?
|
| Brain | 1 | 2023 | 1489 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2018 | 1225 | 0.030 |
Why?
|
| Interdisciplinary Communication | 1 | 2015 | 107 | 0.030 |
Why?
|
| Air Pressure | 1 | 1994 | 5 | 0.030 |
Why?
|
| Respiratory Mechanics | 1 | 1994 | 53 | 0.030 |
Why?
|
| Psychology | 1 | 2013 | 47 | 0.030 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2015 | 114 | 0.030 |
Why?
|
| Cohort Studies | 3 | 2005 | 2442 | 0.030 |
Why?
|
| United States Department of Veterans Affairs | 1 | 2017 | 513 | 0.030 |
Why?
|
| Appointments and Schedules | 1 | 2013 | 53 | 0.030 |
Why?
|
| Cybernetics | 1 | 1993 | 1 | 0.030 |
Why?
|
| Membranes | 1 | 1993 | 19 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2020 | 1915 | 0.030 |
Why?
|
| Action Potentials | 1 | 1993 | 103 | 0.030 |
Why?
|
| Time | 1 | 2012 | 27 | 0.030 |
Why?
|
| Aorta | 1 | 1993 | 106 | 0.020 |
Why?
|
| Echocardiography, Doppler | 1 | 1993 | 131 | 0.020 |
Why?
|
| Exercise Tolerance | 1 | 2012 | 70 | 0.020 |
Why?
|
| Residence Characteristics | 1 | 2013 | 224 | 0.020 |
Why?
|
| Oxygen Consumption | 1 | 2012 | 202 | 0.020 |
Why?
|
| Hemodynamics | 1 | 1993 | 236 | 0.020 |
Why?
|
| Thromboembolism | 1 | 2011 | 70 | 0.020 |
Why?
|
| Gait | 1 | 2012 | 114 | 0.020 |
Why?
|
| Heart Ventricles | 1 | 1993 | 251 | 0.020 |
Why?
|
| Ion Channel Gating | 1 | 1991 | 44 | 0.020 |
Why?
|
| Exercise Test | 1 | 2012 | 234 | 0.020 |
Why?
|
| Predictive Value of Tests | 2 | 2004 | 1032 | 0.020 |
Why?
|
| Ion Channels | 1 | 1991 | 87 | 0.020 |
Why?
|
| Sensitivity and Specificity | 2 | 2004 | 1095 | 0.020 |
Why?
|
| Radioimmunoassay | 1 | 2010 | 56 | 0.020 |
Why?
|
| Clinical Protocols | 1 | 2011 | 134 | 0.020 |
Why?
|
| Models, Theoretical | 1 | 2011 | 258 | 0.020 |
Why?
|
| Self Report | 1 | 2012 | 366 | 0.020 |
Why?
|
| Hemorrhage | 1 | 2011 | 277 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2010 | 198 | 0.020 |
Why?
|
| Lung | 1 | 1994 | 833 | 0.020 |
Why?
|
| Hospitals, University | 1 | 2006 | 50 | 0.020 |
Why?
|
| Animals | 3 | 1994 | 19661 | 0.020 |
Why?
|
| Workload | 1 | 2006 | 121 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2004 | 195 | 0.010 |
Why?
|
| Decision Making | 1 | 2006 | 390 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2004 | 1311 | 0.010 |
Why?
|
| Infant | 1 | 2004 | 1527 | 0.010 |
Why?
|
| 1,2-Dipalmitoylphosphatidylcholine | 1 | 1994 | 4 | 0.010 |
Why?
|
| Surface Tension | 1 | 1994 | 15 | 0.010 |
Why?
|
| Tantalum | 1 | 1994 | 5 | 0.010 |
Why?
|
| In Vitro Techniques | 1 | 1994 | 475 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 1994 | 570 | 0.010 |
Why?
|
| Radiography | 1 | 1994 | 506 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 1994 | 636 | 0.010 |
Why?
|
| Rats | 1 | 1994 | 1913 | 0.010 |
Why?
|
| Models, Biological | 1 | 1994 | 1142 | 0.000 |
Why?
|